Abstract:Molecular imaging can be defined as the in vivo visualization, characterization, and measurement of biologic processes at the cellular and molecular level. Contrast to "classical" diagnostic imaging, the molecular imaging aims to probe fundamental molecular processes that are the basis of disease rather than to image the end effects of these molecular alterations. Central to the molecular imaging in cancer is the development of high specific imaging probes for effective detection of cancer markers that are expressed differently in tumor cells or tissues. The applications of nanotechnology in molecular imaging field lead to the emergence of nanoprobes. One of the advantages of such imaging probes is their flexibility when conjugated with targeting ligands and imaging moieties. Additionally, different imaging modalities can be merged into a single nanoparticle to achieve multimodalities probes for comprehensive lesions imaging. Furthermore, nanoparticles can be readily modified to alter their pharmacokinetics, prolong their plasma half lives, enhance their stability in vivo, improve the targeting efficiency and reduce nonspecific binding. These properties of nanoparticles make them promising candidates of high performance probes in molecular imaging. In this chapter, we summarize the innovative nanoparticle-based imaging probes that have been investigated for in vivo molecular imaging in cancer diagnosis.

Nanoparticle Probes And Molecular Imaging In Cancer